Cargando…

The endocrine prevention of breast cancer.

Detalles Bibliográficos
Autor principal:	Fentiman, I. S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1989
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247347/ https://www.ncbi.nlm.nih.gov/pubmed/2679842

Ejemplares similares

Male breast cancer: a review
por: Fentiman, IS
Publicado: (2009)

γ-Glutamyl transferase and breast cancer risk
por: Fentiman, I S, et al.
Publicado: (2010)

Preventing invasive breast cancer using endocrine therapy
por: Thorat, Mangesh A., et al.
Publicado: (2017)

Surgical options for male breast cancer
por: Fentiman, Ian S.
Publicado: (2018)

Neoadjuvant treatment for male breast cancer
por: Fentiman, Ian Stuart
Publicado: (2023)

Treatment of cancer in the elderly.
por: Fentiman, I. S.
Publicado: (1991)

Can mood disorder in women with breast cancer be identified preoperatively?
por: Ramirez, A. J., et al.
Publicado: (1995)

Multidisciplinary Atlas of Breast Surgery
por: Fentiman, Ian S
Publicado: (1998)

Body weight and vascular invasion in post-menopausal women with breast cancer.
por: Badwe, R. A., et al.
Publicado: (1997)

Histopathology of breast cancer in relation to age.
por: Fisher, C. J., et al.
Publicado: (1997)

Serum progesterone and prognosis in operable breast cancer.
por: Mohr, P. E., et al.
Publicado: (1996)

Cell proliferation measured by MIB1 and timing of surgery for breast cancer.
por: Cooper, L. S., et al.
Publicado: (1998)

The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer
por: Horn, Sarah L., et al.
Publicado: (2010)

ENDOCRINE ASPECTS OF BREAST CANCER
Publicado: (1958)

Endocrine Relationships in Breast Cancer
por: Barnes, D. M.
Publicado: (1982)

Synchronous bilateral breast cancer in a patient with Klinefelter’s syndrome
por: Hoque, H M R, et al.
Publicado: (2010)

Gamma-glutamyl transferase: risk and prognosis of cancer
por: Fentiman, I S
Publicado: (2012)

Pharmacogenomics of endocrine therapy in breast cancer
por: Ingle, James N
Publicado: (2013)

Time trends in breast cancer survival: experience in a single centre, 1975-89.
por: Bradburn, M. J., et al.
Publicado: (1998)

The influence on survival of delay in the presentation and treatment of symptomatic breast cancer
por: Richards, M A, et al.
Publicado: (1999)

Endocrine and targeted treatments for breast cancer
por: Hudis, Clifford A
Publicado: (2007)

Statins and endocrine resistance in breast cancer
por: Hyder, Tara, et al.
Publicado: (2021)

Mucoid breast carcinomas: histology and prognosis.
por: Fentiman, I. S., et al.
Publicado: (1997)

Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.
por: Dowsett, M., et al.
Publicado: (1984)

Treatment of screen detected ductal carcinoma in situ: a silver lining within a grey cloud?
por: Fentiman, I. S.
Publicado: (1990)

Elastosis and response to endocrine therapy in human breast cancer.
por: Masters, J. R., et al.
Publicado: (1979)

Breast cancer: further metabolic-endocrine risk markers?
por: Stoll, B. A.
Publicado: (1997)

Family history and survival in premenopausal breast cancer.
por: Mohammed, S. N., et al.
Publicado: (1998)

Patterns of metastasis in women with metachronous contralateral breast cancer
por: Vichapat, V, et al.
Publicado: (2012)

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
por: Alves, Carla L., et al.
Publicado: (2021)

Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer.
por: Conroy, S. E., et al.
Publicado: (1998)

VAV3 mediates resistance to breast cancer endocrine therapy
por: Aguilar, Helena, et al.
Publicado: (2014)

Association of Endocrine Therapy and Dementia in Women with Breast Cancer
por: Thompson, Mikayla R, et al.
Publicado: (2021)

Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies
por: Shawky, Michael S., et al.
Publicado: (2016)

Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Hokkaido Adjuvant Chemo-Endocrine Therapy for Breast Cancer Study Group.
por: Uchino, J., et al.
Publicado: (1994)

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983)

Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer
por: Ingle, James N
Publicado: (2008)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

Predictive markers of endocrine response in breast cancer
por: Mosly, Duniya, et al.
Publicado: (2018)

Pathways to Endocrine Therapy Resistance in Breast Cancer
por: Haque, Md. Moquitul, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_soqni96jou0p9pavfe1fh7q68a